What volatile organic compounds (VOCs) are produced by Escherichia coli, and how do their profiles differ between susceptible and resistant strains?

Label:chem

Topic
Escherichia coli (E. coli) is a widely studied bacterial species known for its metabolic diversity. The study investigates the volatile organic compounds (VOCs) produced by both carbapenem-susceptible and carbapenem-resistant strains of E. coli. VOCs are metabolic byproducts that can serve as biomarkers for bacterial identification and monitoring of infections. Understanding the differences in VOC profiles between susceptible and resistant strains can aid in the development of rapid diagnostic techniques for bacterial infections, particularly in critical care settings such as ventilator-associated pneumonia (VAP).

From: "Profiling of Volatile Metabolites of Escherichia coli Using Gas Chromatography–Mass Spectrometry", Int. J. Mol. Sci. 2025, 26(17), 8191;
Answer
The study identified a total of 57 VOCs from the susceptible strain and 41 from the resistant strain of E. coli. The VOCs were categorized based on their emission patterns during bacterial growth:
Continuous Release Proportional to Bacterial Load: Compounds like ethanol, 1-propanol, and 1-butanol were released in quantities directly proportional to the bacterial load. These compounds are likely useful for monitoring the progression of an infection.
Temporary Maximum Release: Compounds such as isoprene, 2-butenal, and dimethyl disulfide showed a temporary peak in emission during the logarithmic growth phase. These VOCs could serve as early indicators of bacterial infections.
Compound Uptake: Aldehydes like methacrolein and 3-methylbutanal were taken up by the bacteria, indicating their use as a nutrient source.
Return to Home Chemical List
Knowledge you may be interested in
How was the NMN biosynthetic pathway implemented in E. coli for intracellular production? What challenges are associated with the industrial-scale production of nicotinamide mononucleotide (NMN)? How is nicotinamide mononucleotide (NMN) typically synthesized in biological systems? What is the significance of nicotinamide mononucleotide (NMN) in cellular metabolism and aging? What is the impact of biofilm formation by Escherichia coli (E. coli) on antibiotic resistance and treatment efficacy? What is the role of Escherichia coli (E. coli) in biofilm formation and its impact on human and animal health? What is the synergistic effect of Ferulic Acid (FA) with antibiotics against E. coli? How does Ferulic Acid (FA) affect the transcription of biofilm-related genes in E. coli? What is the role of Ferulic Acid (FA) in inhibiting biofilm formation by Escherichia coli (E. coli)? What are the potential pharmaceutical applications of tocotrienols extracted from Hypericum perforatum L.? What is the relationship between specific phylogenetic lineages of Klebsiella pneumoniae and the risk of death in bloodstream infections? What is the significance of carbapenem resistance in Klebsiella pneumoniae, and how has it evolved in Romania? How do different carbapenemases affect the susceptibility of CRKP strains to antibiotics like colistin and cefiderocol? How has the use of antibiotics like colistin and cefiderocol changed over the study period, and what impact has this had on CRKP prevalence? What is the role of the crude extract from Bacillus nakamurai Tie-10 in inhibiting Klebsiella pneumoniae? How does the crude extract from Bacillus nakamurai Tie-10 disrupt the cellular integrity of Klebsiella pneumoniae? What is the effect of the crude extract from Bacillus nakamurai Tie-10 on the biofilm formation of Klebsiella pneumoniae? How does the crude extract from Bacillus nakamurai Tie-10 affect the expression of virulence-associated genes in Klebsiella pneumoniae? What is the minimum inhibitory concentration (MIC) of the crude extract from Bacillus nakamurai Tie-10 against Klebsiella pneumoniae? What is the new spectrophotometric method developed for analyzing cephalosporins, and how does it work?